Related Experiment Video

Updated: Apr 29, 2026

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

7.6K

Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer

Arjan Gower1, Yisong Wang, Giuseppe Giaccone

  • 1Georgetown University, Washington, DC, USA.

Journal of Molecular Medicine (Berlin, Germany)
|May 24, 2014
PubMed

Insights

Targeted therapies have advanced non-small-cell lung cancer treatment, but resistance remains a challenge. Future strategies aim to overcome or prevent resistance for better patient outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Targeted therapies have transformed advanced non-small-cell lung cancer (NSCLC) treatment.
  • Molecular profiling guides personalized treatment strategies for lung adenocarcinoma.
  • Acquired resistance to targeted therapies limits long-term clinical benefit.

Purpose of the Study:

  • To review the evolution of targeted therapies in NSCLC.
  • To discuss mechanisms of acquired resistance to these therapies.
  • To highlight future directions in overcoming treatment resistance.

Main Methods:

  • Literature review of recent advancements in lung cancer therapy.
  • Analysis of genomic classification and resistance mechanisms.
  • Discussion of emerging therapeutic strategies.

Main Results:

  • Targeted therapies offer significant initial efficacy in NSCLC.
  • Tumor cells frequently develop resistance, leading to treatment failure.
  • Understanding resistance mechanisms is crucial for developing next-generation drugs.

Conclusions:

  • Continued evolution in genomic classification and resistance mechanisms is observed.
  • Development of novel therapeutic strategies is essential to overcome resistance.
  • Future clinical results are expected to improve with new approaches to combat lung cancer resistance.

More Related Videos

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

557
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.8K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.6K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K